Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

PTC Therapeutics Company Profile (NASDAQ:PTCT)

Consensus Ratings for PTC Therapeutics (NASDAQ:PTCT) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 8 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $77.89 (24.38% upside)

Current Analysts' Coverage Summary for PTC Therapeutics (NASDAQ:PTCT)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/3/2015BarclaysInitiated CoverageOverweight$100.00ViewTweet This Rating  Share This Rating on StockTwits
3/2/2015WedbushBoost Price Target$81.00ViewTweet This Rating  Share This Rating on StockTwits
3/2/2015JPMorgan Chase & Co.DowngradeOverweight -> NeutralViewTweet This Rating  Share This Rating on StockTwits
3/2/2015Roth CapitalBoost Price TargetBuy$58.00 -> $75.00ViewTweet This Rating  Share This Rating on StockTwits
2/24/2015Deutsche BankReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
2/24/2015Credit Suisse Group AGBoost Price Target$100.00ViewTweet This Rating  Share This Rating on StockTwits
1/22/2015RBC CapitalInitiated CoverageOutperform$81.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
12/18/2014Citigroup Inc.Initiated CoverageBuy$81.00ViewTweet This Rating  Share This Rating on StockTwits
10/13/2014Bank of AmericaReiterated RatingBuy$50.00 -> $48.00ViewTweet This Rating  Share This Rating on StockTwits
10/6/2014Cowen and CompanyDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
7/31/2014OppenheimerInitiated CoverageOutperform$60.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2014B. RileyInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
11/8/2013Evercore ISIBoost Price TargetOverweight$30.00 -> $34.50ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013Jefferies Group LLCBoost Price Target$25.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/29/2013 forward)